Research Progress of Anti-lung Cancer Drug-related Interstitial Lung Disease
Lung cancer is the cancer with the highest incidence and mortality rate worldwide. In addition to the diversified treatment and prolonged lifespan in view of the development of medical technology, the side effect of medicine should not be ignored. Drug-induced interstitial lung disease (DI-ILD) is a...
Saved in:
| Main Authors: | Zhimin XIAO, Yan GU |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2025-04-01
|
| Series: | Chinese Journal of Lung Cancer |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2025.106.11 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug-Induced Interstitial Lung Disease
by: Wei-I Lee, et al.
Published: (2019-01-01) -
Research Progress of Immune Checkpoint Inhibitors Combined with Anti-Angiogenic Drugs in Treatment of Advanced Non-Small Cell Lung Cancer
by: Aiju ZENG, et al.
Published: (2025-06-01) -
Nivolumab-induced interstitial lung disease in the patient with melanoma
by: Marcin Morawski, et al.
Published: (2024-02-01) -
Immunotherapy for Extensive-stage Small Cell Lung Cancer:
Research Progress and Future Perspectives
by: Yuling ZHONG, et al.
Published: (2024-11-01) -
Ixekizumab-induced interstitial lung disease: a case report confirmed by transbronchial lung cryobiopsy
by: Shota Kaburaki, et al.
Published: (2024-12-01)